Use of the 1.5T Elekta Unity MR-Linac was associated with reduced rates of erectile dysfunction at 6, 12, and 18 months in ...

Treatment-related adverse effects were reported in 97.2% of heavily pretreated patients with uterine serous carcinoma taking ...

Traditionally, HER2 status has been determined by immunohistochemistry (IHC) and in situ hybridization (ISH), distinguishing ...

Panelists discuss how molecular testing and liquid biopsies are crucial for tracking estrogen receptor 1 (ESR1) mutations in patients with metastatic breast cancer, particularly as a mechanism of ...

Video content above is prompted by the following: The Oncology Nursing News program focuses on treatment strategies for ESR1-mutant hormone receptor-positive, HER2-negative breast cancer. Led by ...

A nurse practitioner gives her advice for managing adverse events during treatment with talquetamab for multiple myeloma. Oncology nurses and advanced practice providers (APPs) administering treatment ...

The amount of CDK4/6-targeting treatment options available for patients with HR-positive breast cancer allows providers to ...

Toilet Cover May Significantly Reduce Aerosol Exposure in Hospital Bathrooms ...

Retifanlimab-dlwr (Zynyz) has been granted approval from the FDA for treatment of locally recurrent or metastatic squamous ...